跳至主要内容
临床试验/CTRI/2019/08/020786
CTRI/2019/08/020786尚未招募未知

TO COMPARE THE EFFICACY, SAFETY, COST- EFFECTIVENESS AND QUALITY OF LIFE OF AZILSARTAN VERSUS TELMISARTAN, IN PATIENTS OF STAGE I HYPERTENSIO

Department of Pharmacology0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. New patients with hypertension i.e not on any antihypertensive therapy.
  • 2. Adult males and females of age 21 years or more.

排除标准

  • 1. Patients already on anti-hypertensives.
  • 2. Patients with hypersensitivity to AZL or telmisartan.
  • 3. Pregnant/ lactating women/ women planning to conceive.
  • 4. Evidence of severe renal disorder.
  • 5. Patients with hepatic insufficiencies.
  • 6. Patients unwilling or unable to comply with the study proceedings.
  • 7. Patients with severe bradycardia, cardiogenic shock, heart block, sick sinus syndrome, decompensated heart failure, bronchial asthma, hypothyroidism, CVA, CAD.
  • 8. Patients with other co morbidities like hyperthyroidism, anxiety disorders.
  • 9. Patients with refractory hypertension.

研究者

相似试验